HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

eicosapentaenoic acid ethyl ester

ameliorates symptoms of ischemia caused by arteriosclerosis obliterans
Also Known As:
EPA-E; Epadel; ethyl all-cis-5,8,11,14,17-icosapentaenoate; ethyl eicosapentaenoate; ethyl icosapentaenoate
Networked: 56 relevant articles (11 outcomes, 7 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Stirtan, William G: 3 articles (05/2015 - 02/2013)
2. Braeckman, Rene A: 3 articles (05/2015 - 02/2013)
3. Soni, Paresh N: 3 articles (05/2015 - 02/2013)
4. Saito, Yasushi: 3 articles (11/2013 - 01/2013)
5. Harada, Tsuyoshi: 3 articles (04/2011 - 10/2003)
6. Horrobin, David F: 3 articles (11/2004 - 10/2002)
7. Bays, Harold E: 2 articles (05/2015 - 02/2013)
8. Ballantyne, Christie M: 2 articles (05/2015 - 02/2013)
9. Tatsuno, Ichiro: 2 articles (11/2013 - 05/2013)
10. Ootake, Jun: 2 articles (11/2013 - 05/2013)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Atherosclerosis
3. Thrombosis (Thrombus)
4. Diabetes Mellitus
5. Hypertension (High Blood Pressure)

Related Drugs and Biologics

1. eicosapentaenoic acid ethyl ester
2. Eicosapentaenoic Acid
3. Lipids
4. Glucose (Dextrose)
5. ethyl eicosapentaenoic acid
6. Pravastatin (Pravachol)
7. Blood Glucose (Blood Sugar)
8. Arachidonic Acid (Vitamin F)
9. olive oil
10. rho-Associated Kinases

Related Therapies and Procedures

1. Oral Administration